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ABSTRACT
Background Acute kidney injury (AKI) is a signiﬁcant
cause of morbidity and mortality. Early identiﬁcation may
improve the outcome and in 2012 our hospital
introduced an automated AKI alert system for early
detection and management of AKI.
Objectives Using an automated AKI alert system we
analysed whether early review and intervention by the
Critical Care and Outreach (CCOT) team improved
patient outcomes in AKI and whether serum bicarbonate
was useful in predicting outcomes in patients with AKI.
Methods In a retrospective analysis we identiﬁed
patients who triggered an AKI alert from 20 April 2012
to 20 September 2013 and collected data on mortality,
length of stay, need for intensive care admission and
renal replacement therapy (RRT).
Results 994 AKI alerts were generated and analysed.
Patients with bicarbonate outside the normal range had
signiﬁcantly higher mortality. Bicarbonate <22 mmol/L
was associated with a mortality of 25.7% (49/191)
compared with 16.9% (39/231) when 22–29 mmol/L
(p=0.047, χ2). Those patients reviewed ≥1 day after
AKI alert by CCOT compared with those seen on the day
of the alert had a 2.4 times increase in mortality and
were 7 times more likely to require RRT acutely.
Conclusions Electronically identiﬁed AKI alerts identify
patients at high risk of morbidity and mortality. In this
group AKI alerts preceded CCOT review by a mean of
2 days. This represents a window for supportive
interventions, which may explain improved outcomes in
those reviewed earlier. The addition of serum
bicarbonate offers a further method of risk stratifying
patients at greater risk of death.
INTRODUCTION
Acute kidney injury (AKI) is common in hospital
with recent multicentre studies reporting rates of up
to 7% in the USA.1–3 It is also increasingly recog-
nised as a very signiﬁcant cause of morbidity and
mortality in hospital inpatients. Multiple studies
have shown inhospital and 90 day mortality of
around 20–25%, and 50% for those requiring acute
renal replacement therapy (RRT).4 5 It is also clear
that AKI is associated with development of chronic
kidney disease (CKD) or worsening of existing CKD
even in those who recover renal function after an
episode of AKI.6 7 Rates of end-stage renal disease
and long-term mortality are also higher.8 9
AKI is estimated to cost the National Health
Service (NHS) £620 million/year10 and yet despite
the high mortality and impact of AKI, early identi-
ﬁcation of at-risk patients has been poor. A
National Conﬁdential Enquiry report in 2009 high-
lighted several deﬁciencies in the care of patients
with AKI including delayed identiﬁcation and
delayed referral for specialist input.10 Given the
paucity of effective medical treatments for estab-
lished AKI, early detection and supportive interven-
tions are likely to be critical; this has promoted the
implementation of ‘AKI alerts’ to aid early detec-
tion and management.11 12 A national patient
safety alert issued in June 2014 has recommended
that all NHS hospitals in England, providing path-
ology services, implement an algorithm for AKI
alerting by March 2015 (see box 1).13
From April 2012 our hospital has operated an
automatic alerting system whereby every creatinine
processed is compared with the previous (if avail-
able within the preceding 90 days). If the current
value is ≥150% the previous, an automated
message is generated and attached to the report.
Since January 2013 an additional test for venous
bicarbonate is automatically added to any biochem-
istry request triggering an AKI alert. Our study had
two objectives; ﬁrst, was the additional, (unre-
quested) result for venous bicarbonate useful in
determining which patients were more likely to
require Intensive treatment unit (ITU) admission,
acute RRTor have increased mortality? Our second
objective analysed a subgroup of patients who had
AKI but were also reviewed by Critical Care and
Outreach (CCOT). We aimed to identify if in these
patients early intervention by CCOTwas associated
with improved patient outcome, mortality or
reduced need for ITU admission and acute RRT
compared with later assessment.
METHODS
Patients
A database of all patients who triggered an AKI alert
between 20 April 2012 and 20 September 2013 was
generated by the biochemistry laboratory. Alerts
generated for patients in the outpatient department,
general practice or emergency department were
excluded if the patients were not admitted to hos-
pital within 24 h. Patients in whom the AKI alert
was artefactual were excluded, this included patients
who were established on RRT (either acute or
chronic), patients with a single spuriously low or
high creatinine, postpartum women and patients
with icteric or lipaemic samples.
Subgroup of patients referred to CCOT
By cross-referencing the AKI database with the clin-
ical database for CCOT referrals we identiﬁed a
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subgroup of patients who triggered an AKI alert but were also
seen by CCOTon the basis of a physiological deterioration. AKI
alerts were not part of CCOT referral criteria at this time.
Patients who were seen by CCOT as part of routine step-down
from ITU care were excluded. Data were collected retrospect-
ively on stage of AKI, length of stay, trigger for and timing of
CCOTreview, ITU admission and mortality.
Clinical data
Data were collected from patients’ electronic records on age,
gender, stage of AKI, venous bicarbonate, mortality, admission
to ITU and acute RRT. Stage of AKI was deﬁned using KDIGO
biochemical staging criteria for severity of AKI (stage 1
corresponds to serum creatinine 1.5–1.9 times baseline, stage 2,
2.0–2.9 times baseline and stage 3, >3.0 times baseline).
Progression of AKI from stage 1 to stage 2 or stage 3 was identi-
ﬁed by looking at serial creatinine results over subsequent days
for individual patients after the AKI alert was generated.
Patients were identiﬁed who had AKI stage 1 but then had a
subsequent creatinine which when compared with the initial
baseline would correspond to AKI stage 2 or stage 3.
Data analysis
Stage of AKI, mortality and proportion of patients needing ITU
admission and acute RRT were calculated and compared
between patients with normal bicarbonate (22–29 mmol/L),
those with low bicarbonate (<22 mmol/L) and high bicarbonate
(>29 mmol/L).
Patients reviewed by CCOT were divided into two groups,
those seen prior to or on the day of the AKI alert and those
seen after the AKI alert. Stage of AKI, mortality, need for ITU
admission, acute RRTand length of hospital stay were compared
between the two groups.
Statistical analysis
Data are reported as mean values with range unless otherwise
stated. Student’s t test was used for continuous variables and χ2
test for the difference in proportions between two groups. For
χ2 tests where the contingency table is larger than 2×2,
Bonferroni correction is used for post hoc analysis. Results are
reported as statistically signiﬁcant when p<0.05.
RESULTS
Alerts
Over the 16-month period of analysis, there were 1421 AKI
alerts generated; 272 of these were in outpatients or patients
seen in the emergency department but not admitted, 79 were in
pregnant or postpartum women and 76 alerts were excluded as
not a true AKI. Of the 76 excluded, 27 were because the cre-
atinine result was the patient’s actual baseline or there was
clearly an erroneous result (in some cases this was documented
as a drip arm or diluted sample), 8 alerts were in existing
haemodialysis patients, 35 patients were receiving acute haemo-
ﬁltration in the ITU and in 3 cases the ratio calculated manually
was <1.5.
Patients
Nine hundred and ninety-four AKI alerts were included; this
represented 940 separate inpatient episodes and 831 different
patients. The mean age was 72.27 years (18.3–101.9 years), 437
(52.6%) were female and 394 (47.4%) male. Six hundred and
thirty (63.3%) of the alerts were for AKI stage 1, 265 (26.7%)
AKI stage 2 and 99 (10.0%) AKI stage 3. Of the patients who
had multiple episodes of AKI on a single inpatient episode 1
each had four or ﬁve AKI alerts, 2 had three AKI alerts and 41
patients had two alerts. Eighty-one patients (9.7%) had multiple
admissions with AKI, of these 1 patient each was admitted ﬁve
or six times, 2 were admitted four times, 14 on three occasions
and 65 were admitted twice.
Time to AKI alert after admission
Median time to AKI alert after admission was 0 days (0–227
days), 561 patients had an AKI alert at the time of admission
and a further 123 patients had an AKI alert within the next
48 h.
Morbidity and mortality
There were 190 admissions to ITU and 46 patients required
acute RRT. Mortality was calculated on the basis of death in
hospital and as an outcome of each inpatient episode; overall
mortality was 24.9% (207 patients), in those admitted to ITU
mortality was 40.5% (77 patients) and in patients requiring
RRT acutely was 47.8% (22 patients). Mortality by stage of AKI
is shown in ﬁgure 1.
Progression of AKI
Of the alerts for AKI stage 1, 10.3% (65) progressed to a higher
stage of AKI, 47 of these progressed to AKI stage 2, 9 pro-
gressed directly to stage 3 at the next result recorded and 9 pro-
gressed to stage 2 and then onto stage 3. The initial progression
in AKI occurred a mean of 2.88 days after the initial AKI alert
was generated (0–12 days). The mortality in this group with
progressive AKI while an inpatient was 35.4% overall and mor-
tality in those who progressed from AKI stage 1 to stage 3 was
Figure 1 Inpatient mortality by stage of AKI alert. AKI, acute kidney
injury.
Box 1 National Patient Safety Alert June 2014
▸ Issued to all NHS England Hospitals
▸ A national algorithm standardising the deﬁnition of AKI has
been agreed
▸ Algorithm should be integrated into a laboratory information
management system
▸ Priority is adoption of an e-alert system which notiﬁes
clinicians when a patient has AKI
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signiﬁcantly higher than those whose AKI was detected initially
at stage 3—66.7% vs 23.9% (p=0.001).
Using serum bicarbonate to predict patient outcomes
Five hundred and twenty-ﬁve AKI alerts had a bicarbonate assay
added, in 16 cases the sample was not processed due to insufﬁ-
cient serum remaining or the sample being too old giving 509
AKI alerts with results for bicarbonate. For the purpose of ana-
lysis of outcomes, where patients had more than one AKI alert
for a single admission the bicarbonate and AKI stage for the last
recorded episode of AKI was used. One hundred and ninety-one
patients had a bicarbonate <22 mmol/L, 231 22–29 mmol/L
and 58 >29 mmol/L. A higher proportion of patients with low
bicarbonate had an AKI stage 3 (11.5% (22 patients) of patients
with bicarbonate <22 mmol/L compared with 7.4% (17
patients) of patients with bicarbonate 22–29 mmol/L) although
this was not signiﬁcant.
Serum bicarbonate and patient outcome
Mortality was higher when bicarbonate is outside of the normal
range; in those with a bicarbonate <22 mmol/L mortality was
25.7% (49 patients) compared with 16.9% (39 patients) when
bicarbonate was 22–29 mmol/L and 27.5% (16 patients) when
>29 mmol/L (p=0.047, χ2) (ﬁgures 2 and 3). This was most
pronounced in patients with AKI stage 1; mortality 24.3% (27
patients) when bicarbonate <22 mmol/L, 12.0% (19 patients)
when 22–29 mmol/L and 25.6% (10 patients) when >29 mmol/
L (p=0.015, χ2). Signiﬁcantly more patients with an abnormal
bicarbonate required ITU admission; 25.7% (49 patients) when
<22 mmol/L, 14.7% (34 patients) when 22–29 mmol/L and
24.1% (14 patients) when >29 mmol/L (p=0.015, χ2). The
need for acute RRT was greatest in those with low bicarbonate
compared with the two other groups, 7.3% vs 2.2% vs 1.7%
(p=0.019, χ2) (ﬁgure 3).
Outcome of patients with AKI also referred to CCOT
Over the same time period 97 patients with an AKI alert were
referred to CCOT on the basis of physiological deterioration
(such as tachycardia, oliguria, hypotension or hypoxia) or
because medical or nursing staff had concerns regarding their
condition. The mean age of this group was 71.67 years (28–96
years), 50.5% patients were female and mean length of stay was
22.4 days (2–163 days). Compared with the whole cohort of
patients with AKI there were slightly more patients with an AKI
stage 3 and less with an AKI stage 1 (not signiﬁcant), 57 cases
(58.8%) of AKI stage 1 and 20 cases (20.6%) each of AKI stage
2 and AKI stage 3. Eighteen (18.6%) patients were seen post-
operatively and 47 (48.5%) had infection or sepsis implicated in
the aetiology of their deterioration. Forty-seven patients
(48.5%) reviewed by CCOT required admission to ITU and 13
(13.4%) acute RRT. The overall inpatient mortality of patients
seen by CCOTwho also had AKI was 37.1%; this was 33.3% in
AKI stage 1, 45.0% in AKI stage 2 and 40.0% in AKI stage 3.
Timing of CCOT review and outcome
As referral to CCOT was on the basis of physiological decline
and not AKI there was often a signiﬁcant window of time
between AKI alert and CCOT review; mean +1.93 days (−10 to
+33 days). To analyse if this delay to CCOT review altered
patient outcomes the patients were stratiﬁed into those who
were reviewed by CCOT prior to or on the day of AKI alert
and those seen on subsequent days (table 1).
Patients seen prior to or on the day of AKI alert had signiﬁ-
cantly lower mortality, 19.4% vs 47.5% in those seen from the
day after AKI alert (p=0.0085, χ2), and mortality increased
with increasing length of time to CCOT review (ﬁgure 4). This
difference was seen in those with AKI stage 1 (13.6% vs 45.7%,
p=0.027, χ2) and in patients with AKI stage 2 and stage 3, mor-
tality 28.6% in those seen prior to or on the day of AKI alert
and 50% in those seen on subsequent days, a large difference
although this was not signiﬁcant due to smaller numbers in this
group. Signiﬁcantly more patients required acute RRT in the
group seen later, 19.7% vs 2.8% (p=0.04, χ2) and this differ-
ence was seen in patients with AKI stage 1 and AKI stage 2 and
stage 3 (ﬁgure 5). In patients who left hospital alive, length of
stay was shorter in those who were seen up to and including the
day of the AKI alert, 19.3 days vs 24.7 days. In those with AKI
stage 2 or stage 3 the difference in length of stay appeared even
more pronounced, 15.9 days vs 30.0 days, although these results
were not signiﬁcant as due to high mortality the numbers in
each group were small.
DISCUSSION
In keeping with other published work our study shows that AKI
is common and associated with a very high mortality: 24.9% in
the whole cohort rising to 47.8% in patients who required RRT
Figure 2 Inpatient mortality stratiﬁed by bicarbonate level.
Figure 3 Mortality, need for ITU admission and acute renal
replacement therapy (RRT) in all patients compared by bicarbonate
level. *p<0.05.
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acutely. This compares to a published mortality of 3% for
non-ST elevation myocardial infarction,14 7% for ST elevation
myocardial infarction15 and 12% for acute stroke.16 In the
setting of AKI high and low venous bicarbonates predicted a
markedly worse outcome. The group with low serum bicarbon-
ate (<22 mmol/L) had higher mortality and was more likely to
be admitted to ITU or need RRT acutely than the group with
bicarbonate within the normal range. Similarly those with high
serum bicarbonate (>29 mmol/L) also had a near doubling of
mortality and higher rates of admission to ITU but were not
more likely to require acute RRT. This is perhaps not surprising
as high bicarbonate almost certainly represents additional organ
failure in the form of acute or chronic respiratory failure and
these patients are unable to compensate for metabolic acidosis
secondary to AKI. Likewise, those patients with low bicarbonate
are likely to represent those with more severe illness. Regardless
of the cause low or high venous bicarbonate appears to be a
simple and cheap predictor (addition of this test represents a
cost to our hospital of approximately £1000 over an 18-month
period) of substantial mortality which may be useful in identify-
ing and prioritising patients at risk at an earlier stage, hopefully,
increasing the opportunity to improve outcomes.
Given the poor outcomes in patients developing AKI and the
lack of an effective treatment of acute tubular injury, the hope
would be that early identiﬁcation and intervention may reduce
the injury by removing toxins and effective resuscitation. In
view of this, it is intriguing that within the subgroup of patients
with AKI who were reviewed by CCOT, those assessed ≥1 days
after their AKI alert had an increase in mortality by a factor of
2.4, were 7 times more likely to require RRTacutely and had an
increased length of stay by a mean of 5 days. Referral to CCOT
was on the basis of physiological decline, not AKI, and it may
be that those patients seen on the day of their AKI alert repre-
sent those with a more acute event prompting early and more
aggressive intervention. Clearly we cannot say from a retrospect-
ive study that if patients were seen by CCOTon the day of their
AKI alert, their outcomes would be better. However, given the
severe consequences of AKI, adding an AKI alert to the referral
indications for CCOT is very appealing, not least because for
many patients CCOT referral would be nearly 2 days earlier
than if left to trigger by physiological parameters.
All NHS hospitals in England must have instituted an AKI
alert algorithm by March 2015 and our results offer scope for
how alerts can be used either to predict those at higher risk or
to improve patient outcomes. Early identiﬁcation and assess-
ment with the rapid removal of nephrotoxins and introduction
of supportive measures is likely to be critical if we wish to
improve outcomes in patients with AKI.
Limitations
The limitations of our study include its retrospective data collec-
tion and the likelihood of false negatives—episodes of AKI may
have been missed where no creatinine was available in the last
90 days or where the creatinine was already elevated from the
patient’s previous baseline. The number of patients included in
the subgroup reviewed by CCOT is small and there may well be
confounding factors between the patients who were reviewed
earlier rather than later which were not identiﬁed on retrospect-
ive analysis.
Future work
Our study shows an association between low serum bicarbonate
and poorer outcomes. In order to further investigate this it
would be useful to have a comprehensive multivariate analysis
or to add bicarbonate to other acute illness scoring systems and
identify if bicarbonate associates with poor outcomes. There
was also a suggestion from our data that those patients who
have progressive AKI do worse than those with AKI that do not,
Table 1 Patient demographics when patients are stratified by
timing of CCOT review
Seen up to or on day of
AKI alert
Seen after day of
AKI alert
N 36 61
Age (years) 71.81 (28.24–96.27) 71.59 (30.59–96.80)
Female/Male 18/18 31/30
AKI stage 1 22 (61.1%) 35 (57.3%)
AKI stage 2 8 (22.2%) 12 (19.7%)
AKI stage 3 6 (16.7%) 14 (22.9%)
AKI, acute kidney injury; CCOT, Critical Care and Outreach.
Figure 4 Increasing mortality with increasing time from acute kidney
injury (AKI) alert to Critical Care and Outreach (CCOT) review. p=0.018
(χ2).
Figure 5 Increased requirement for renal replacement therapy (RRT) in
patients reviewed later by Critical Care and Outreach (CCOT) following
acute kidney injury (AKI) alert compared with earlier review. *p<0.05.
4 Prendecki M, et al. Postgrad Med J 2015;0:1–5. doi:10.1136/postgradmedj-2015-133496
Original article
perhaps implying that the underlying pathophysiology is
ongoing in the former as opposed to a single insult in the latter.
Either way electronic identiﬁcation of patients with progressive
AKI may also help identify patients at greater risk. This could
potentially be achieved by adjusting the alert algorithm to use
admission creatinine as the baseline rather than the previous
result directly.
Main messages
▸ Patients with AKI and low or high serum bicarbonate have a
signiﬁcantly higher mortality and are more likely to require
ITU admission than those with bicarbonate within the
normal range.
▸ A delay in review by Critical Care and Outreach is associated
with signiﬁcantly increased mortality, requirement for acute
renal replacement therapy and length of stay.
Current research questions
▸ Can biochemical markers other than bicarbonate be used to
risk stratify patients with AKI?
▸ Which supportive interventions can improve patient
outcomes in AKI?
▸ Can a scoring system be developed to identify those at
highest risk of AKI on admission to hospital?
▸ What are the long-term outcomes in patients who have had
an episode of AKI; are there any factors that can predict
those at risk of a worse outcome after discharge from
hospital?
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